Literature DB >> 27174477

The Airway in Idiopathic Pulmonary Fibrosis: Protecting the Lung or Promoting Disease?

Changwan Ryu1, Robert J Homer2, Erica L Herzog1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27174477      PMCID： PMC4872674          DOI： 10.1164/rccm.201601-0055ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

1.  PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.

Authors:  Marta Bueno; Yen-Chun Lai; Yair Romero; Judith Brands; Claudette M St Croix; Christelle Kamga; Catherine Corey; Jose D Herazo-Maya; John Sembrat; Janet S Lee; Steve R Duncan; Mauricio Rojas; Sruti Shiva; Charleen T Chu; Ana L Mora
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

2.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.

Authors:  Carmel J Stock; Hiroe Sato; Carmen Fonseca; Winston A S Banya; Philip L Molyneaux; Huzaifa Adamali; Anne-Marie Russell; Christopher P Denton; David J Abraham; David M Hansell; Andrew G Nicholson; Toby M Maher; Athol U Wells; Gisela E Lindahl; Elisabetta A Renzoni
Journal:  Thorax       Date:  2013-01-15       Impact factor: 9.139

4.  TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.

Authors:  Justin M Oldham; Shwu-Fan Ma; Fernando J Martinez; Kevin J Anstrom; Ganesh Raghu; David A Schwartz; Eleanor Valenzi; Leah Witt; Cathryn Lee; Rekha Vij; Yong Huang; Mary E Strek; Imre Noth
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

5.  Fibrotic extracellular matrix activates a profibrotic positive feedback loop.

Authors:  Matthew W Parker; Daniel Rossi; Mark Peterson; Karen Smith; Kristina Sikström; Eric S White; John E Connett; Craig A Henke; Ola Larsson; Peter B Bitterman
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

6.  Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Authors:  Timothy S Blackwell; Andrew M Tager; Zea Borok; Bethany B Moore; David A Schwartz; Kevin J Anstrom; Ziv Bar-Joseph; Peter Bitterman; Michael R Blackburn; William Bradford; Kevin K Brown; Harold A Chapman; Harold R Collard; Gregory P Cosgrove; Robin Deterding; Ramona Doyle; Kevin R Flaherty; Christine Kim Garcia; James S Hagood; Craig A Henke; Erica Herzog; Cory M Hogaboam; Jeffrey C Horowitz; Talmadge E King; James E Loyd; William E Lawson; Clay B Marsh; Paul W Noble; Imre Noth; Dean Sheppard; Julie Olsson; Luis A Ortiz; Thomas G O'Riordan; Tim D Oury; Ganesh Raghu; Jesse Roman; Patricia J Sime; Thomas H Sisson; Daniel Tschumperlin; Shelia M Violette; Timothy E Weaver; Rebecca G Wells; Eric S White; Naftali Kaminski; Fernando J Martinez; Thomas A Wynn; Victor J Thannickal; Jerry P Eu
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

7.  Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.

Authors:  Linlin Yang; Yuan Chen; Tiantian Cui; Thomas Knösel; Qing Zhang; Kai Frederik Albring; Otmar Huber; Iver Petersen
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

8.  Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis.

Authors:  Ivana V Yang; Christopher D Coldren; Sonia M Leach; Max A Seibold; Elissa Murphy; Jia Lin; Rachel Rosen; Amanda J Neidermyer; David F McKean; Steve D Groshong; Carlyne Cool; Gregory P Cosgrove; David A Lynch; Kevin K Brown; Marvin I Schwarz; Tasha E Fingerlin; David A Schwartz
Journal:  Thorax       Date:  2013-06-19       Impact factor: 9.139

9.  Lung volumes and emphysema in smokers with interstitial lung abnormalities.

Authors:  George R Washko; Gary M Hunninghake; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; David A Lynch; John M Brehm; Katherine P Andriole; Alejandro A Diaz; Ramin Khorasani; Katherine D'Aco; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

Review 10.  Mechanistic basis of desmosome-targeted diseases.

Authors:  Caezar Al-Jassar; Hennie Bikker; Michael Overduin; Martyn Chidgey
Journal:  J Mol Biol       Date:  2013-08-02       Impact factor: 5.469
View more
  8 in total

1.  Update in Interstitial Lung Disease 2016.

Authors:  Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

Review 2.  Update in Interstitial Lung Disease 2019.

Authors:  Sydney B Montesi; Jolene H Fisher; Fernando J Martinez; Moisés Selman; Annie Pardo; Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

3.  Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Authors:  Ezra R Miller; Rachel K Putman; Alejandro A Diaz; Hanfei Xu; Raúl San José Estépar; Tetsuro Araki; Mizuki Nishino; Sergio Poli de Frías; Tomoyuki Hida; James Ross; Harvey Coxson; Josée Dupuis; George T O'Connor; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu; George Washko; Gary M Hunninghake
Journal:  Ann Am Thorac Soc       Date:  2019-04

4.  M2 macrophages have unique transcriptomes but conditioned media does not promote profibrotic responses in lung fibroblasts or alveolar epithelial cells in vitro.

Authors:  Elissa M Hult; Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-07-07       Impact factor: 6.011

5.  A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.

Authors:  John E McDonough; Dries S Martens; Naoya Tanabe; Farida Ahangari; Stijn E Verleden; Karen Maes; Geert M Verleden; Naftali Kaminski; James C Hogg; Tim S Nawrot; Wim A Wuyts; Bart M Vanaudenaerde
Journal:  Respir Res       Date:  2018-07-09

Review 6.  The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B.

Authors:  Qinghua Zhang; Yan Wang; Danhua Qu; Jinyan Yu; Junling Yang
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

7.  The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.

Authors:  Xiaozheng Wu; Wen Li; Zhenliang Luo; Yunzhi Chen
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

8.  Ciliated (FOXJ1+) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients.

Authors:  Sofia C Wijk; Pavan Prabhala; Anna Löfdahl; Annika Nybom; Stefan Lang; Hans Brunnström; Leif Bjermer; Gunilla Westergren-Thorsson; Mattias Magnusson
Journal:  Cells       Date:  2022-03-18       Impact factor: 6.600
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.